Premium Bio-Pharma Private Limited
About Premium Bio-Pharma Private Limited
Data last updated:
Premium Bio-Pharma Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC236236.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rachna Lamba and Tulsi Ram Rana.
Its last annual general meeting (AGM) was held on 15 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 209 Rishabh Tower Karkardooma Complx, Delhi, India – 110092.
As per the financials filed for FY 2026, the company reported a revenue of ₹81,917. For the same year it recorded a net profit of ₹72,017 (net margin 87.9%) and EBITDA of ₹72,017 (EBITDA margin 87.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Premium Bio-Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address209 Rishabh Tower Karkardooma Complx, Delhi, India – 110092
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Premium Bio-Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Premium Bio-Pharma Private Limited
FY 2025 filings availablePremium Bio-Pharma Private Limited reported revenue of ₹81,917 for FY 2026.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72,017 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,017 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 87.9% | ||||
| Net Profit Margin | 87.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Premium Bio-Pharma Private Limited, buy the company report.
Board of directors of Premium Bio-Pharma Private Limited
Premium Bio-Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rachna Lamba | Director | 21 May 2012 | 14 Years 5 Months | Current |
| Tulsi Ram Rana | Director | 21 May 2012 | 14 Years 5 Months | Current |
Auditor
Premium Bio-Pharma Private Limited is audited by Gaur & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gaur & Associates | FY 2017 | 005354C |
Shareholding
The shareholding of Premium Bio-Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Premium Bio-Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Premium Bio-Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Premium Bio-Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Premium Bio-Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Premium Bio-Pharma Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Rachna Lamba was appointed as Director on 21 May 2012.
Frequently asked questions
Premium Bio-Pharma is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 May 2012 (14+ years old) and is registered under CIN U24232DL2012PTC236236.
Premium Bio-Pharma has 2 current directors:
- Rachna Lamba - Director
- Tulsi Ram Rana - Director
The latest financial statements of Premium Bio-Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 July 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Premium Bio-Pharma is U24232DL2012PTC236236. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premium Bio-Pharma was incorporated on 21 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Rachna Lamba was appointed as Director on 21 May 2012. Tulsi Ram Rana was appointed as Director on 21 May 2012.
The registered office of Premium Bio-Pharma is at 209 Rishabh Tower Karkardooma Complx, Delhi, India – 110092.
Premium Bio-Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Premium Bio-Pharma is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.
Premium Bio-Pharma can be reached at its registered office: 209 Rishabh Tower Karkardooma Complx, Delhi, India – 110092.